SCHEMBL163350

SCHEMBL163350

CN[C@@H](CO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170982 1.00
SCHEMBL181375 1.00
Hydrochloric Acid SCHEMBL28497287 0.97
Water SCHEMBL27785467 0.97
SCHEMBL790222 0.97
Hydrochloric Acid SCHEMBL2852741 0.97
Hydrochloric Acid SCHEMBL2852737 0.97
Hydrochloric Acid SCHEMBL27763690 0.95 TGFBR1 (0.47)
Formic Acid SCHEMBL28393660 0.91 TGFBR1 (0.44)
Serine SCHEMBL16397814 0.87 TGFBR1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4579 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746912-A1 ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES Simris Biologics GmbH (DE) 2026-05-27 EP claimed
EP-4743120-A1 MOLECULAR DEGRADERS FOR THE TREATMENT OF IGA NEPHROPATHY Biohaven Therapeutics Ltd. (VG) 2026-05-20 EP claimed
EP-4745237-A1 RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF YUN HO BIO CO., LTD (CN) 2026-05-20 EP claimed
CN-122070296-A Insect neuropeptide analogs 索拉斯塔生物有限公司 2026-05-19 CN claimed
CN-116457073-B Solvent solution and method KC8捕集技术有限公司 2026-05-15 CN claimed
CN-122028793-A Fungicidal compositions 先正达农作物保护股份公司 2026-05-12 CN claimed
EP-4727654-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
EP-4727655-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-1069906-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTRATE CANCER Merck & Co., Inc. (US) 2001-01-24 EP claimed
WO-1999044628-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO., INC. (US) 1999-09-10 WO claimed
EP-0813544-A4 1998-01-07 EP claimed
EP-0813544-A1 BRADYKININ ANTAGONIST PEPTIDES INCORPORATING N-SUBSTITUTED GLYCINES CORTECH, INC. (US) 1997-12-29 EP claimed
US-5565493-A ADMINISTERING N-METHYL-L-SERINE KANEBO, LTD. (JP) 1996-10-15 US claimed
WO-1995029691-A1 PROLINE PHOSPHONATE DERIVATIVES GEORGIA TECH RESEARCH CORPORATION (US) 1995-11-09 WO claimed
WO-1995024422-A1 BRADYKININ ANTAGONIST PEPTIDES INCORPORATING N-SUBSTITUTED GLYCINES CORTECH, INC. (US) 1995-09-14 WO claimed
EP-0506965-B1 COLLAGEN METABOLISM AMELIORANT AND ITS USE KANEBO LTD (JP) 1995-06-28 EP claimed
US-5332758-A N-methylserine KANEBO, LTD. (JP) 1994-07-26 US claimed
EP-0506965-A1 COLLAGEN METABOLISM AMELIORANT AND ITS USE KANEBO LTD. (JP) 1992-10-07 EP claimed